Seminars in Oncology Nursing
Volume 23 , Pages 1-8 , February 2007

The ABCs of Colorectal Cancer

References 

  1. Sun W, Haller DG. The Saltz article reviewed. Oncology. 2005;19:1158–1160
  2. Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: Current options, current evidence. J Clin Oncol. 2005;23:4553–4560
  3. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol. 2004;22:229–237
  4. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005;10:250–261
  5. Saltz LB. Metastatic colorectal cancer: Is there one standard approach?. Oncology. 2005;19:1147–1154
  6. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal (liver) metastases. Ann Surg Oncol. 2001;8:347–353
  7. Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004;15:933–939
  8. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  9. Ishibe N, Freedman AN. Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis. Cancer Invest. 2001;19:524–539
  10. Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol. 2006;59:114–124
  11. Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: Hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull. 2002;64:27–43
  12. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–321
  13. Waterston AM, Cassidy J. Adjuvant treatment strategies for early colon cancer. Drugs. 2005;14:1935–1947
  14. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  15. Chien C, Morimoto LM, Tom J, et al. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104:629–639
  16. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: Understanding the differences in outcomes between African Americans and Whites. Med Clin North Am. 2005;89:771–793
  17. Stefanidis D, Pollock BH, Miranda J, et al. Colorectal cancer in Hispanics. Am J Clin Oncol. 2006;29:123–126
  18. National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology – v.2.2006, Colon cancer, and v.2.2006, Rectal Cancer. 2006;Available at: http://www.nccn.org/professionals/physicians_gls/PDF/colon.pdf (accessed May 26)
  19. Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control. 2005;16:201–213
  20. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: Prospects for molecular stool analysis. Nature Rev Cancer. 2005;5:199–209
  21. Weitz J, Koch M, Debus J, et al. Colorectal cancer. Lancet. 2005;365:153–165
  22. Rudy DR, Zdon MJ. Update on colorectal cancer. Am Fam Physician. 2000;61:1759–1769
  23. Calabrese P, Mecklin J-P, Järvinen HJ, et al. Numbers of mutations to different types of colorectal cancer. BMC Cancer 255;5:126-132.
  24. Syngal S, Stoffel E, Chung D, et al. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006;106:277–283
  25. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, GA: American Cancer Society; 2006;
  26. Lafata JE, Williams LK, Ben-Menachem T, et al. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104:1356–1361
  27. Mahon SM. Colorectal cancer screening: A review of the evidence. Clin J Oncol Nurs. 2004;8:536–540
  28. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27–43
  29. Greenwald B. A comparison of three stool tests for colorectal cancer screening. Med Surg Nurs. 2005;14:292–299
  30. Pignone M, Levin B. Recent developments in colorectal cancer screening and prevention. Am Fam Physician. 2002;66:297–302
  31. Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24:386–393
  32. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–1425
  33. Safi F, Beyer HG. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev. 1993;124:544–560
  34. Wong JH, Johnson DS, Hemmings D, et al. Assessing the quality of colorectal cancer staging. Arch Surg. 2005;140:881–887
  35. Fusai G, Davidson BR. Management of colorectal liver metastases. Colorectal Dis. 2003;5:2–23
  36. Leen E. The detection of occult liver metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg. 1999;6:7–15
  37. Viale PH, Fung A, Zitella L. Advanced colorectal cancer: Current treatment and nursing management with economic considerations. Clin J Oncol Nurs. 2005;9:541–552
  38. Wilkes GM. Therapeutic options in the management of colon cancer: 2005 update. Clin J Oncol Nurs. 2005;9:31–44

PII: S0749-2081(06)00111-2

doi: 10.1016/j.soncn.2006.08.001

Seminars in Oncology Nursing
Volume 23 , Pages 1-8 , February 2007

Article Tools

* Image Usage & Resolution